Metformin exerts a synergistic effect with venetoclax by downregulating Mcl-1 protein in acute myelo...
Metformin exerts a synergistic effect with venetoclax by downregulating Mcl-1 protein in acute myeloid leukemia
About this item
Full title
Author / Creator
Publisher
Wyoming: Ivyspring International Publisher Pty Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Wyoming: Ivyspring International Publisher Pty Ltd
Subjects
More information
Scope and Contents
Contents
Background: Recently, one of the specific BH3-mimetics, Venetoclax has been approved by FDA providing new options for newly diagnosed AML patient especially who are unfitted to receive conventional chemotherapy. Though the clinical success of venetoclax has been achieved in clinical outcomes such as complete remission (CR) and overall survival. Acq...
Alternative Titles
Full title
Metformin exerts a synergistic effect with venetoclax by downregulating Mcl-1 protein in acute myeloid leukemia
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8518002
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8518002
Other Identifiers
ISSN
1837-9664
E-ISSN
1837-9664
DOI
10.7150/jca.60208
